As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...

Roche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...

Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate c...

Roche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...

A major private hospital group warns of a crisis for advanced cancer patients under the Central Government Health Scheme. A reimbursement c...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

In India, cervical cancer is the second most common in women, making up close to 18 per cent of the new cancer cases, the International Age...

At the Christie hospital in Manchester, medical professionals are currently overseeing approximately 30 clinical trials. Encouragingly, the...

The Mediterranean diet will play an important role in the success of immunotherapy.

Immunotherapy should be given as early as possible to achieve a lasting remission of the disease.

The duo showed how different strategies for inhibiting brakes on the immune system that can be used in cancer treatment.

"Immunotherapy may be a life-saving treatment and can be used as an alternative to the much more toxic high dose chemotherapy that is curre...

Merck is betting big on its oncology pipeline, in the field of immunotherapy that has come to define new-age cancer treatment.

Kulkarni, Sengupta and their colleagues have found a method to watch cancer cells in the body die in real time, as a patient is treated wit...

Merck’s competitors have lined up their own immunotherapy drugs. They include Bristol Myers Squibb (BMS), Roche & Novartis & several smalle...

New and considerable optimism over cancer drugs will drive deal-making in pharma over the decade, with companies weak in this segment tryin...